J&J Skin Care Stands Out Amid Beleaguered Consumer Business
This article was originally published in The Rose Sheet
Neutrogena launches carried Johnson & Johnson’s U.S. skin-care sales in the U.S. to $453 million for the first quarter, up 6.3% from the same period a year ago. Overall, however, the firm’s Consumer Healthcare sales declined 2.2% in the U.S. to $1.32 billion.
You may also be interested in...
Seven of 10 CBD-containing supplement products tested in a lab did not contain the levels of CBD advertised on the label, says hemp, CBD and natural health product information publisher Remedy Reviews. Most products also were found to contain heavy metals.
P&G approach to advertising for SK-II skin care drove double-digit sales growth in new users and prompted a 27% increase in searches for the line. P&G has saved $1bn from cost-cutting in ad agencies and advertising implemented over past five years, says chief brand officer Marc Pritchard.
HBW Market News: DSM Taps Co-CEOs, Bayer Consumer Ex-US Changes Ad Firm, Recover 180° Sponsors Champ, More
Former PepsiCo exec Beraud's Sh’nnong Beverage launches Ma Functional Iced Teas with CBD+ Natural Botanicals; Chobani expands beyond yogurt with oat-based products; Recover 180° sponsors boxer Deontay Wilder; Mighty Self Balance CBD targets inflammation; Oki CBD drinks reach Florida; Bayer consumer taps ad firm MullenLowe; and Royal DSM will have co-CEOs when CEO Sijbesma leaves.